SUBSTANCE: invention provides a method for producing a heterogenous skin cell population implying the sampling of a skin biopsy material at a depth of 2 mm, tissue homogenisation in 0.9% aqueous sodium chloride at temperature +23 … +25°C, recovery of homogenate, filtration of the homogenate through an inert filter cloth with the pore diameter of 20 mcm, centrifugation of the homogenate at 400 g for 5 minutes at temperature +23 … +25 C.
EFFECT: skin cell separation and viability preservation.
A friend asked today: Do you watch football?
To answer him I say, there is deceit, pure and simple. How can I not watch if football is literally everywhere, and I have the same eyes and ears... However, his question inspired me one memory. Read further...
Living Parallel, part II-Experience.
Bolivia, Uyuni salt marsh, Incahuasi island.
Taking into account the universality of the pathogenesis of the wound process and the existence of substances predictably affecting the nature of the immune response in the skin and certain functions of its constituent cells (including reparative), the development of a new biotechnological agent for healing skin wounds of different etiology is justified and relevant.
This determined the aim and objectives of this study. Read more...
Friends, I have a great event! Every letter matters, but today is a special day – the first time in my life I received a letter from the ruling monarch. More...
